Central Nervous System Clinical Trial
Official title:
Brain Networks and Mobility Function: B-NET
Rapidly accumulating evidence indicates that the central nervous system (CNS) plays a pivotal role in mobility function with age-associated CNS changes strongly contributing to declining mobility. Studies linking the brain to mobility have used anatomical measures like brain volume and white matter integrity, and suggest that damage to the connecting fibers of the brain (white matter) is related to mobility impairment. Unfortunately, age-related structural white matter damage appears irreversible and only indirectly indicates the functional connectivity between brain regions. It is believed that functional brain network analyses have the potential to identify individuals that may benefit from interventions prior to the development of irreversible white matter lesions. The current project will assess both physical and cognitive function and integrate these variables with measures of brain network connectivity.
Studies linking the brain to mobility have used anatomical measures like brain volume and white matter integrity, and suggest that damage to the connecting fibers of the brain (white matter) is related to mobility impairment. Unfortunately, age-related structural white matter damage appears irreversible and only indirectly indicates the functional connectivity between brain regions. The preliminary data show that directly assessed patterns of functional connectivity correlate with mobility function and can be changed by interventions that improve mobility function. It is not known how changes in CNS functional connectivity relate to changes in mobility, information critical for the design of interventions targeting CNS connectivity to improve mobility impairments. It is clear that structural connectivity underlies functional connectivity, and that structural brain lesions result in altered functional connections. B-NET will assess white matter (WM) disease burden and microstructural changes and relate these changes to functional brain network connectivity. We hypothesize that because sensory motor cortex community structure (SMC-CS) characterizes current brain organization, it will be associated with mobility function independently of anatomical damage markers. Such knowledge may permit earlier identification of persons at high risk for mobility decline and facilitate earlier and better targeted interventions. ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04014491 -
The Effects of Exercise Training on Corticospinal System in Overhead Athletes With Shoulder Impingement Syndrome
|
N/A | |
Terminated |
NCT01006109 -
Recording and Modulation of Neuronal Mechanisms During Operant Conditioning: a MEG Study
|
||
Recruiting |
NCT02559752 -
Computer-based Neurocognitive Assessment in Children With Central Nervous System Tumors Receiving Proton Beam Radiation Therapy
|
||
Terminated |
NCT04644315 -
A Home-Based Approach Study to Evaluate the Efficacy and Safety of Alectinib in Locally-Advanced or Metastatic ALK-Positive Solid Tumors
|
Phase 2 | |
Completed |
NCT01531920 -
A Study in Healthy Subjects to Determine the Effects When Alcohol is Administered With Perampanel
|
Phase 1 | |
Completed |
NCT02652260 -
Effects of Switching From ATRIPLAâ„¢ (Efavirenz, Tenofovir, Emtricitabine) to MK-1439A (Doravirine, Tenofovir, Lamivudine) in Virologically-Suppressed Participants (MK-1439A-028)
|
Phase 2 | |
Recruiting |
NCT01541800 -
Circulating microRNAs as Disease Markers in Pediatric Cancers
|
N/A | |
Completed |
NCT02343718 -
Vinblastine and Temsirolimus in Pediatrics With Recurrent or Refractory Lymphoma or Solid Tumours Including CNS Tumours
|
Phase 1 | |
Completed |
NCT03830762 -
Xanamemâ„¢ in Healthy Elderly Subjects
|
Phase 1 | |
Completed |
NCT01527006 -
Pharmacokinetics, Efficacy, and Safety of Perampanel Oral Suspension on Seizure Frequency in Pediatric Subjects Maintained on One to Three Stable Antiepileptic Drugs
|
Phase 2 | |
Completed |
NCT01517087 -
Studying Motor Neuron Tests
|
||
Recruiting |
NCT05627986 -
Sensorimotor Cortex Excitability in Shoulder Impingement Syndrome
|
||
Completed |
NCT01432288 -
Touch and Attention MRI Study
|
N/A | |
Completed |
NCT00067067 -
Investigating Endothelial Precursor Cells (EPCs)
|
N/A | |
Completed |
NCT03268239 -
Contrast-enhanced 3D T1-weighted Gradient-echo Versus Spin-echo 3 Tesla MR Sequences in the Detection of Active Multiple Sclerosis Lesions
|
N/A | |
Recruiting |
NCT04846764 -
Rapid Declarative Neocortical Declarative Learning in Aging and Memory Diseases (ANéRAVIMM)
|
N/A |